A review on human toxoplasmosis

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 11, 2012, Pages 805-814

  Saadatnia, Geita ^a   Golkar, Majid ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Laboratory diagnosis; Prevention; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; TOXOPLASMA GONDII VACCINE;

ANTIGEN RECOGNITION; CHORIORETINITIS; CONGENITAL TOXOPLASMOSIS; ENCEPHALITIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; GENETIC POLYMORPHISM; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOADSORBENT; LATEX AGGLUTINATION TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREGNANT WOMAN; PREVALENCE; PROTIST LIFE CYCLE STAGE; REVIEW; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

HUMANS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84867838567     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.693197     Document Type: Review

References (75)

1. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of fetus and newborn infant, 6th ed. Philadelphia: Elsevier-Saunders Company, 2006. pp. 947 - 1091.
2. Weiss LM, Kim K. Toxoplasma gondii: the model apicomplexan: perspectives and methods. Illustrated ed. Academic Press; 2007. pp. 367-86.
3. Peyron F, Garweg JG, Wallon M, Descloux E, Rolland M, Barth J. Long-term impact of treated congenital toxoplasmosis on quality of life and visual performance. Pediatr Infect Dis J 2011;30:597 - 600.
4. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-76.
5. Antinori A, Larussa D, Cingolani A, Lorenzini P, Bossolasco S, Finazzi MG, et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis 2004;39:1681-91.
6. Mohraz M, Mehrkhani F, Jam S, SeyedAlinaghi S, Sabzvari D, Fattahi F, et al. Seroprevalence of toxoplasmosis in HIV (+) /AIDS patients in Iran. Acta Med Iran 2011;49: 213-8.
7. Petersen E, Dubey JP. Biology of toxoplasmosis. In: Joynson DHM, Wreghitt TG, editors. Toxoplasmosis: a comprehensive clinical guide 2001. Cambridge, UK: Cambridge University Press; 2001. pp. 1 - 42.
8. Behzadi R, Roohvand F, Razavi MR, Hovanessian H, Assmar M. Genotyping of Toxoplasma gondii strains isolated from patients and mice by PCR-RFLP assay. Iranian Journal of Biotechnology 2003;1:82-6.
9. Stillwaggon E, Carrier CS, Sautter M, McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis 2011;5:e1333.
10. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 2002;185(Suppl 1):S73 - 82.
11. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 2009;39:1385 - 94.
12. Bojar I, Szymanska J. Environmental exposure of pregnant women to infection with Toxoplasma gondii - state of the art. Ann Agric Environ Med 2010;17:209 - 14.
13. Jones JL, Dubey JP. Waterborne toxoplasmosis - recent developments. Exp Parasitol 2010;124:10 - 25.
14. Flegr J, Hrda S, Tachezy J. The role of psychological factors in questionnaire-based studies on routes of human toxoplasmosis transmission. Cent Eur J Public Health 1998;6: 45 - 50.
15. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis 2009;49:878 - 84.
16. J ones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999- 2004, decline from the prior decade. Am J Trop Med Hyg 2007;77:405 - 10.
17. Pereira KS, Franco RM, Leal DA. Transmission of Toxoplasmosis (Toxoplasma gondii) by Foods. Adv Food Nutr Res 2010;60:1 - 19.
18. Rorman E, Zamir CS, Rilkis I, Ben-David H. Congenital toxoplasmosis - prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol 2006;21:458 - 72.
19. Jongert E, Roberts CW, Gargano N, Forster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 2009;104: 252 - 66.
20. Innes EA. Vaccination against Toxoplasma gondii: an increasing priority for collaborative research? Expert Rev Vaccines 2010;9:1117 - 9.
21. Buxton D, Thomson KM, Maley S, Wright S, Bos HJ. Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine. Vet Rec 1993; 133:310 - 2.
22. Varella IS, Canti IC, Santos BR, Coppini AZ, Argondizzo LC, Tonin C, et al. Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil. Mem Inst Oswaldo Cruz 2009;104:383 - 8.
23. Benard A, Petersen E, Salamon R, Chene G, Gilbert R, Salmi LR. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill 2008;13. pii: 18834.
24. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfi eld R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858 - 63.
25. Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999 - 2002. Arch Dis Child 2006;91:661 - 5.
26. Gomez-Marin JE, de-la-Torre A, Angel-Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis 2011;5:e1195.
27. Roser D, Nielsen HV, Petersen E, Saugmann-Jensen P, Norgaard-Pedersen B. Congenital toxoplasmosis - a report on the Danish neonatal screening programme 1999 - 2007. J Inherit Metab Dis 2010;33:S241 - 7.
28. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz 2009;104:320 - 44.
29. Abdul-Ghani R. Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation. Parasitol Res 2011;108:505-12.
30. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004;42:941 - 5.
31. Bastien P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg 2002;96(Suppl 1):S205 - 15.
32. Dabil H, Boley ML, Schmitz TM, Van Gelder RN. Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis. Arch Ophthalmol 2001;119: 1315 - 22.
33. Burg JL, Grover CM, Pouletty P, Boothroyd JC. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989;27:1787 - 92.
34. Okay TS, Yamamoto L, Oliveira LC, Manuli ER, Andrade Junior HF, Del Negro GM. Significant performance variation among PCR systems in diagnosing congenital toxoplasmosis in Sao Paulo, Brazil: analysis of 467 amniotic fluid samples. Clinics (Sao Paulo) 2009;64:171 - 6.
35. Homan WL, Vercammen M, De Braekeleer J, Verschueren H. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol 2000;30:69 - 75.
36. Reischl U, Bretagne S, Kruger D, Ernault P, Costa JM. Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 2003;3:7.
37. Menotti J, Garin YJ, Thulliez P, Serugue MC, Stanislawiak J, Ribaud P, et al. Evaluation of a new 5′ -nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat. Clin Microbiol Infect 2010;16:363 - 8.
38. Jones CD, Okhravi N, Adamson P, Tasker S, Lightman S. Comparison of PCR detection methods for B1, P30, and 18S rDNA genes of T. gondii in aqueous humor. Invest Ophthalmol Vis Sci 2000;41:634 - 44.
39. Calderaro A, Piccolo G, Gorrini C, Peruzzi S, Zerbini L, Bommezzadri S, et al. Comparison between two real-time PCR assays and a nested-PCR for the detection of Toxoplasma gondii. Acta Biomed 2006;77:75 - 80.
40. Buchbinder S, Blatz R, Rodloff AC. Comparison of real-time PCR detection methods for B1 and P30 genes of Toxoplasma gondii. Diagn Microbiol Infect Dis 2003;45:269 - 71.
41. Sterkers Y, Varlet-Marie E, Cassaing S, Brenier-Pinchart MP, Brun S, Dalle F, et al. Multicentric comparative analytical performance study for molecular detection of low amounts of Toxoplasma gondii from simulated specimens. J Clin Microbiol 2010;48:3216 - 22.
42. Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004;132:541 - 8.
43. Villena I, Aubert D, Brodard V, Quereux C, Leroux B, Dupouy D, et al. Detection of specific immunoglobulin E during maternal, fetal, and congenital toxoplasmosis. J Clin Microbiol 1999;37:3487 - 90.
44. Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 1948;108:660 - 3.
45. Chatterton JM, Evans R, Ashburn D, Joss AW, Ho-Yen DO. Toxoplasma gondii in vitro culture for experimentation. J Microbiol Methods 2002;51:331 - 5.
46. Wilson M, Jones JL, McAuley JB. Toxoplasma. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manuel of clinical microbiology, 8th ed. ASM Press; 2003. pp. 1970 - 80.
47. Peloux Y, Couzineau P, Baufi ne-Ducrocq H, Tayot JL, Jacquot D. Direct agglutination test for toxoplasma. Role of immunoglobulins 19S and 7S. Preliminary notes. Ann Biol Clin (Paris) 1973;31:185 - 92.
48. Johnson J, Duffy K, New L, Holliman RE, Chessum BS, Fleck DG. Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii. J Clin Pathol 1989;42:536-41.
49. Dannemann BR, Vaughan WC, Thulliez P, Remington JS. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Micro biol 1990;28:1928 - 33.
50. Montoya JG, Berry A, Rosso F, Remington JS. The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis. J Clin Microbiol 2007;45:1463 - 8.
51. Payne RA, Francis JM, Kwantes W. Comparison of a latex agglutination test with other serological tests for the measurement of antibodies to Toxoplasma gondii. J Clin Pathol 1984;37:1293 - 7.
52. Holliman RE, Johnson J, Duffy K, New L. Discrepant toxoplasma latex agglutination test results. J Clin Pathol 1989;42:200 - 3.
53. Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162:270 - 3.
54. Pinon JM, Dumon H, Chemla C, Franck J, Petersen E, Lebech M, et al. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001;39:2267 - 71.
55. Sickinger E, Gay-Andrieu F, Jonas G, Schultess J, Stieler M, Smith D, et al. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diagn Microbiol Infect Dis 2008;62:235 - 44.
56. Curdt I, Praast G, Sickinger E, Schultess J, Herold I, Braun HB, et al. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. J Clin Microbiol 2009;47:603 - 13.
57. Pfrepper KI, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, et al. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol 2005;12:977 - 82.
58. Golkar M, Azadmanesh K, Khalili G, Khoshkholgh-Sima B, Babaie J, Mercier C, et al. Serodiagnosis of recently acquired Toxoplasma gondii infection in pregnant women using enzyme-linked immunosorbent assays with a recombinant dense granule GRA6 protein. Diagn Microbiol Infect Dis 2008;61:31 - 9.
59. Suzuki Y, Ramirez R, Press C, Li S, Parmley S, Thulliez P, et al. Detection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women. J Clin Microbiol 2000;38:3967 - 70.
60. Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989;159:736 - 40.
61. Roberts A, Hedman K, Luyasu V, Zufferey J, Bessieres MH, Blatz RM, et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 2001;20:467 - 74.
62. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 2001;183:1248-53.
63. Pietkiewicz H, Hiszczynska-Sawicka E, Kur J, Petersen E, Nielsen HV, Paul M, et al. Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis. Parasitol Res 2007;100:333 - 7.
64. Elyasi H, Babaie J, Fricker-Hidalgo H, Brenier-Pinchart MP, Zare M, Sadeghiani G, et al. Use of dense granule antigen GRA6 in an immunoglobulin G avidity test to exclude acute Toxoplasma gondii infection during pregnancy. Clin Vaccine Immunol 2010;17:1349 - 55.
65. Jenum PA, Stray-Pedersen B. Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol 1998;36:2907-13.
66. Golkar M, Rafati S, Abdel-Latif MS, Brenier-Pinchart MP, Fricker-Hidalgo H, Sima BK, et al. The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women. Diagn Microbiol Infect Dis 2007;58:419 - 26.
67. Franck J, Garin YJ, Dumon H. LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol 2008;46:2334 - 8.
68. Rilling V, Dietz K, Krczal D, Knotek F, Enders G. Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2003;22:174 - 80.
69. Magi B, Migliorini L. Western blotting for the diagnosis of congenital toxoplasmosis. New Microbiol 2011;34:93 - 5.
70. Tissot Dupont D, Fricker-Hidalgo H, Brenier-Pinchart MP, Bost-Bru C, Ambroise-Thomas P, Pelloux H. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2003;22:122 - 5.
71. Pinon JM, Thoannes H, Gruson N. An enzyme-linked immuno-filtration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J Immunol Methods 1985;77:15 - 23.
72. Remington JS, Araujo FG, Desmonts G. Recognition of different Toxoplasma antigens by IgM and IgG antibodies in mothers and their congenitally infected newborns. J Infect Dis 1985;152:1020 - 4.
73. Maudry A, Chene G, Chatelain R, Patural H, Bellete B, Tisseur B, et al. Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clin Vaccine Immunol 2009;16:1322 - 6.
74. Englander M, Young LH. Ocular toxoplasmosis: advances in detection and treatment. International ophthalmology clinics 2011;51:13 - 23.
75. Kotresha D, Noordin R. Recombinant proteins in the diagnosis of toxoplasmosis. APMIS 2010;118:529 - 42.